KLRC2 and COVID-19: Maucourant et al. found low numbers but a strong activation phenotype (Ki-67+, HLA-DR+, CD69+) of NK cells in peripheral blood of COVID-19 patients and adaptive NK cells, with high expression of perforin, NKG2C, and Ksp37, was increased in circulation of patients with severe COVID-19 33.